OHUI SUNSCIENCE LUMINOUS WHITENING SUNBLOCK- ensulizole, octisalate, bemotrizinol, octocrylene, diethylamino hydroxybenzoyl hexy

Država: Združene države Amerike

Jezik: angleščina

Source: NLM (National Library of Medicine)

Aktivna sestavina:

ENSULIZOLE (UNII: 9YQ9DI1W42) (ENSULIZOLE - UNII:9YQ9DI1W42), OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W), BEMOTRIZINOL (UNII: PWZ1720CBH) (BEMOTRIZINOL - UNII:PWZ1720CBH), OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM), DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE (UNII: ANQ870JD20) (DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE - UNII:ANQ870JD20), ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z), TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15

Dostopno od:

LG Household and Healthcare, Inc.

INN (mednarodno ime):

ENSULIZOLE

Sestava:

ENSULIZOLE 3.9 mL in 100 mL

Pot uporabe:

TOPICAL

Tip zastaranja:

OTC DRUG

Status dovoljenje:

OTC monograph not final

Lastnosti izdelka

OHUI SUNSCIENCE LUMINOUS WHITENING SUNBLOCK - ENSULIZOLE, OCTISALATE,
BEMOTRIZINOL, OCTOCRYLENE, DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE,
ZINC OXIDE, TITANIUM
DIOXIDE, ATRACTYLODES JAPONICA ROOT OIL CREAM
LG HOUSEHOLD AND HEALTHCARE, INC.
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may be marketed if they_
_comply with applicable regulations and policies. FDA has not
evaluated whether this product complies._
----------
DRUG FACT
ENSULIZOLE 3.9%
OCTISALATE 4.7%
BEMOTRIZINOL 1.5%
OCTOCRYLENE 5%
DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE 1%
ZINC OXIDE 12.3%
TITANIUM DIOXIDE 3.67%
ATRACTYLODES JAPONICA ROOT OIL 0.0525%
For external use only.
Keep out of reach of children. Is swallowed, get medical help or
contact a Poison Control Center right
away.
Keep out of eyes. Rinse with water to remove.
OHUI SUNSCIENCE LUMINOUS WHITENING SUNBLOCK
ensulizole, octisalate, bemotrizinol, octocrylene, diethylamino
hydroxybenzoyl hexyl benzoate, zinc oxide, titanium
dioxide, atractylodes japonica root oil cream
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:5320 8 -518
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
ENSULIZO LE (UNII: 9 YQ9 DI1W42) (ENSULIZOLE - UNII:9 YQ9 DI1W42)
ENSULIZOLE
3.9 mL
in 10 0 mL
O CTISALATE (UNII: 4X49 Y0 59 6 W) (OCTISALATE - UNII:4X49 Y0 59 6 W)
OCTISALATE
4.7 mL
in 10 0 mL
BEMO TRIZINO L (UNII: PWZ1720 CBH) (BEMOTRIZINOL - UNII:PWZ1720 CBH)
BEMOTRIZINOL
1.5 mL
in 10 0 mL
O CTO CRYLENE (UNII: 5A6 8 WGF6 WM) (OCTOCRYLENE - UNII:5A6 8 WGF6 WM)
OCTOCRYLENE
5 mL
in 10 0 mL
DIETHYLAMINO HYDRO XYBENZO YL HEXYL BENZO ATE (UNII: ANQ8 70 JD20 )
(DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE - UNII:ANQ8 70 JD20 )
DIETHYLAMINO
HYDROXYBENZOYL HEXYL
BENZOATE
1 mL
in 10 0 mL
ZINC O XIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)
ZINC OXIDE
12.3 mL
in 10 0 mL
TITANIUM DIO XIDE (UNII: 15FIX9 V2JP) (TITANIUM DIOXIDE - UNII:15FIX9
V2JP)
TITANIUM DIOXIDE
3.6 7 mL
in 10 0 mL
ATRACTYLO DES JAP